IMPACT OF DANGGUI JIEXIE GRANULE ON RECOVERY AND ACTIVITY LEVELS IN PEDIATRIC ACUTE BRONCHITIS: A FOCUS ON FEVER MANAGEMENT AND PHYSICAL RESILIENCE

Abstract

This study evaluates the efficacy of Danggui Jiexie Granule in conjunction with standard Western medicine for treating fever in children with acute bronchitis and explores its impact on recovery and subsequent physical activity levels. We enrolled 80 pediatric patients diagnosed with acute bronchitis and fever, randomly assigning them to a control group, which received only Western medicine, and a study group, which received both Western medicine and Danggui Jiexie Granule. The treatment duration was 7 days. We measured TCM (Traditional Chinese Medicine) symptom scores, levels of Immunoglobulin M and E (IgM, IgE), and noted clinical efficacy and adverse reactions. Initially, no significant differences were observed between the groups in terms of IgM, IgE levels, or TCM symptom scores. Post-treatment, the study group showed significantly lower levels of IgM and IgE, improved TCM syndrome scores, and a higher total effective rate of 97.50% compared to 80.00% in the control group. The occurrence of adverse reactions was minimal and comparable between the groups. The results suggest that Danggui Jiexie Granule effectively enhances the standard treatment regimen for pediatric acute bronchitis by not only reducing fever more efficiently but also potentially facilitating quicker recovery and return to normal physical activities. This study highlights the importance of integrating traditional Chinese medicine with conventional treatments to optimize health outcomes in pediatric respiratory conditions.